eng wee chua, simon p. harger, martin a. kennedy.  (2019).  metoclopramide-induced acute dystonic reactions may be associated with the cyp2d6 poor metaboliser status and pregnancy-related hormonal changes.  - frontiers in pharmacology.  1-5. 

sheng zhang lim, eng wee chua.  (2018).  revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring.  - frontiers in pharmacology.  . 

chua eng wee, ng pei yuen.  (2016).  minion: a novel tool for predicting drug hypersensitivity?.  - frontiers in pharmacology.  1-7. 

eng wee chua, simone l. cree, kim n. t. ton, klaus lehnert, phillip shepherd, nuala helsby, martin a. kennedy.  (2016).  cross-comparison of exome analysis, next-generation sequencing of amplicons, and the iplex adme pgx panel for pharmacogenomic profiling.  - frontiers in pharmacology.  1-7. 

eng wee chua, simone cree, murray l. barclay, kit doudney, alan aitchison, martin a. kennedy.  (2015).  exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers.  - the pharmacogenomics journal.  414-421. 

eng wee chua, allison l. miller, martin a. kennedy.  (2015).  choice of pcr microtube can impact on the success of long-range pcrs.  - analytical biochemistry.  115-117. 

trent, r.j., cheong, p.l., chua, e.w., kennedy, m.a..  (2013).  progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.  - pathology.  45(4):357-370. 

eng wee chua, james foulds, allison l. miller, martin a. kennedy.  (2013).  novel cyp2d6 and cyp2c19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine.  - pharmacogenetics and genomics.  494-497.